Dermatol Ther (Heidelb). 2014 Jun;4(1):125-9. doi: 10.1007/s13555-014-0045-2. Epub 2014 Feb 22.
Melanoma of non-sun exposed skin in a man with previous prostate cancer: recognition of a recently confirmed association.
Dermatology and therapy
Philip R Cohen
PMID: 24563423
PMCID: PMC4065282 DOI: 10.1007/s13555-014-0045-2
Abstract
BACKGROUND: The association of an increased risk to develop melanoma in patients with prostate cancer has recently been confirmed.
PURPOSE: The postulated etiologic relationship between prostate cancer and the subsequent occurrence of melanoma is discussed.
METHODS: A man with previous prostate cancer who developed melanoma on the plantar surface of his left great toe is described and the possibility of high levels of endogenous androgens promoting not only prostate cancer, but also increased risk of melanoma are reviewed.
RESULTS: Modification of the host immune response, alteration of chromosome telomere length, and/or imbalance of androgen level (presenting as severe teenage acne) are potential mechanisms whereby high levels of endogenous androgens may contribute to the association between prostate cancer and risk of melanoma.
CONCLUSIONS: An increased surveillance for melanoma should be considered in prostate cancer patients. Complete skin examination in men who have had prostate cancer-especially in those individuals diagnosed with prostate cancer prior to age 68 years-should regularly be performed.
References
- Physiol Rev. 2004 Oct;84(4):1155-228 - PubMed
- Br J Cancer. 1980 Apr;41(4):652-6 - PubMed
- Aging (Albany NY). 2013 Jan;5(1):3-17 - PubMed
- Int J Cancer. 2007 Dec 15;121(12):2688-92 - PubMed
- J Clin Oncol. 2013 Dec 10;31(35):4394-9 - PubMed
- Nat Rev Cancer. 2012 Mar 01;12(4):289-97 - PubMed
- Eur J Cancer Prev. 2012 Nov;21(6):552-9 - PubMed
- J Natl Cancer Inst Monogr. 2000;(27):39-66 - PubMed
- Facial Plast Surg Clin North Am. 2013 Feb;21(1):33-42 - PubMed
- Arch Dermatol. 2011 Dec;147(12):1395-402 - PubMed
- Ann N Y Acad Sci. 2006 Nov;1089:168-76 - PubMed
- Melanoma Res. 2002 Dec;12(6):529-38 - PubMed
- J Biol Chem. 2010 Apr 2;285(14):10472-6 - PubMed
- Blood. 2009 Sep 10;114(11):2236-43 - PubMed
- Nat Rev Clin Oncol. 2014 Jan;11(1):24-37 - PubMed
- J Surg Res. 2003 Apr;110(2):393-8 - PubMed
- Cancer Res. 2011 Nov 1;71(21):6758-63 - PubMed
- Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1319-29 - PubMed
- Immunotherapy. 2013 Feb;5(2):169-82 - PubMed
- J Clin Oncol. 2011 Sep 20;29(27):3677-85 - PubMed
- Lancet. 1980 Mar 15;1(8168 Pt 1):562-4 - PubMed
- N Engl J Med. 1989 Jul 20;321(3):129-35 - PubMed
- J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9 - PubMed
- Lancet. 2012 Jan 28;379(9813):361-72 - PubMed
- J Carcinog. 2011;10:33 - PubMed
- CA Cancer J Clin. 2013 Jan;63(1):11-30 - PubMed
- J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26 - PubMed
Publication Types